Cancer-related inflammation and treatment effectiveness

被引：1878

作者：

Diakos, Connie I. ^{[1
]}

Charles, Kellie A. ^{[2
]}

McMillan, Donald C. ^{[3
]}

Clarke, Stephen J. ^{[1
]}

机构：

[1] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW 2006, Australia

[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia

[3] Univ Glasgow, Royal Infirm, Sch Med, Acad Surg Unit, Glasgow, Lanark, Scotland

来源：

LANCET ONCOLOGY | 2014年 / 15卷 / 11期

关键词：

C-REACTIVE PROTEIN; NF-KAPPA-B; COLORECTAL-CANCER; SUPPRESSOR-CELLS; PROGNOSTIC VALUE; TUMOR NECROSIS; LYMPHOCYTE RATIO; MYELOID CELLS; THERAPY; SURVIVAL;

D O I：

10.1016/S1470-2045(14)70263-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Inflammation is a recognised hallmark of cancer that substantially contributes to the development and progression of malignancies. In established cancers, there is increasing evidence for the roles that local immune response and systemic inflammation have in progression of tumours and survival of patients with cancer. This knowledge provides an opportunity to target these inflammatory responses to improve patient outcomes. In this Review, we examine the complex interplay between local immune responses and systemic inflammation, and their influence on clinical outcomes, and propose potential anti-inflammatory interventions for patients with cancer.

引用

页码：E493 / E503

页数：11

共 92 条

[1]

Aarntzen EH, 2012, CANCER RES, V73, P19

[2] Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy [J].

Alexandre, J ;

Gross-Goupil, M ;

Falissard, B ;

Nguyen, ML ;

Gornet, JM ;

Misset, JL ;

Goldwasser, F .

ANNALS OF ONCOLOGY, 2003, 14 (01) :36-41

[3] Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia [J].

Ando, Katsutoshi ;

Takahashi, Fumiyuki ;

Motojima, Shinji ;

Nakashima, Kei ;

Kaneko, Norihiro ;

Hoshi, Kazuei ;

Takahashi, Kazuhisa .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) :E69-E72

[4] C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer [J].

Beer, Tomasz M. ;

Lalani, Alshad S. ;

Lee, Stella ;

Mori, Motomi ;

Eilers, Kristine M. ;

Curd, John G. ;

Henner, W. David ;

Ryan, Christopher W. ;

Venner, Peter ;

Ruether, J. Dean ;

Chi, Kim N. .

CANCER, 2008, 112 (11) :2377-2383

[5] Statins and the risk of colorectal cancer: A meta-analysis of 18 studies involving more than 1.5 million patients [J].

Bonovas, Stefanos ;

Filioussi, Kalitsa ;

Flordellis, Christodoulos S. ;

Sitaras, Nikolaos M. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3462-3468

[6] Bortezomib sensitivity of acute myeloid leukemia CD34+ cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1 [J].

Bosman, Matthieu Cornelis Johannes ;

Schuringa, Jan Jacob ;

Quax, Wilhelmus Johannes ;

Vellenga, Edo .

EXPERIMENTAL HEMATOLOGY, 2013, 41 (06) :530-538

[7] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[8] A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer [J].

Brown, E. R. ;

Charles, K. A. ;

Hoare, S. A. ;

Rye, R. L. ;

Jodrell, D. I. ;

Aird, R. E. ;

Vora, R. ;

Prabhakar, U. ;

Nakada, M. ;

Corringham, R. E. ;

DeWitte, M. ;

Sturgeon, C. ;

Propper, D. ;

Balkwill, F. R. ;

Smyth, J. F. .

ANNALS OF ONCOLOGY, 2008, 19 (07) :1340-1346

[9]

Chan Andrew T, 2013, Recent Results Cancer Res, V191, P1, DOI 10.1007/978-3-642-30331-9_1

[10] Aspirin as adjuvant therapy for colorectal cancer-reinterpreting paradigms [J].

Chia, Whay Kuang ;

Ali, Raghib ;

Toh, Han Chong .

NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) :561-570

← 1 2 3 4 5 6 7 8 9 10 →